TSE:AEZ - AEterna Zentaris Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started Previous CloseC$2.20Today's RangeC$2.11 - C$2.1652-Week RangeC$1.10 - C$4.04Volume1,000 shsAverage Volume12,504 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartEarningsInsider TradesHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Aeterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing and commercializing treatments in oncology, endocrinology and women's health. The Company operates through the biopharmaceutical segment. The Company is engaged in drug development activities and in the promotion of products for others. The Company's principal product candidates are Zoptrex (zoptarelin doxorubicin) and Macrilen (macimorelin) in oncology and endocrinology. The Company focuses on its product candidates Zoptrex and Macrilen, which are in Phase III clinical development, and on a luteinizing hormone-releasing hormone (LHRH)-disorazol Z conjugate (AEZS-138), which is in pre-clinical development in oncology and is available for partnering. The Company's direct and indirect subsidiaries include AEZS GmbH, Zentaris IVF GmbH and Aeterna Zentaris, Inc. Receive AEZ News and Ratings via Email Sign-up to receive the latest news and ratings for AEZ and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange TSE Industry N/A Sub-IndustryN/A SectorN/A Current SymbolTSE:AEZ Previous Symbol CUSIPN/A CIKN/A Webwww.aezsinc.com Phone+1-843-9003223Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings Date5/6/2019 (Estimated) OptionableNot Optionable AEterna Zentaris (TSE:AEZ) Frequently Asked Questions What is AEterna Zentaris' stock symbol? AEterna Zentaris trades on the Toronto Stock Exchange (TSX) under the ticker symbol "AEZ." When is AEterna Zentaris' next earnings date? AEterna Zentaris is scheduled to release their next quarterly earnings announcement on Monday, May 6th 2019. View Earnings Estimates for AEterna Zentaris. Has AEterna Zentaris been receiving favorable news coverage? News stories about AEZ stock have been trending somewhat positive recently, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. AEterna Zentaris earned a media sentiment score of 1.7 on InfoTrie's scale. They also gave media headlines about the biopharmaceutical company a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an impact on the company's share price in the near future. What other stocks do shareholders of AEterna Zentaris own? Based on aggregate information from My MarketBeat watchlists, some companies that other AEterna Zentaris investors own include AEterna Zentaris (AEZS), Tandem Diabetes Care (TNDM), Corus Entertainment (CJR.B), Altagas (ALA), Long Run Exploration (LRE), Tate & Lyle (TATE), Lululemon Athletica (LULU), Maxim Integrated Products (MXIM), Aptose Biosciences (APTO) and Cray (CRAY). Who are AEterna Zentaris' key executives? AEterna Zentaris' management team includes the folowing people: Carolyn Egbert, Independent Chairman of the BoardMichael Ward, President, Chief Executive Officer, DirectorJames Clavijo, Chief Financial Officer (Age 52)Richard Sachse M.D. Ph.D., Senior Vice President, Chief Scientific Officer, Chief Medical OfficerJude Dinges, Chief Commercial Officer, Senior Vice President (Age 58)Eckhard G. Gunther Ph.D., Vice President - Alliance ManagementMichael Teifel, Vice President - Non-Clinical SciencesJohn W. Sharkey Ph.D., Business Development Consultant (Age 60)Philip Allen Theodore, Corporate Secretary (Age 64)David A. Dodd, Director (Age 65) How do I buy shares of AEterna Zentaris? Shares of AEZ and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab. What is AEterna Zentaris' official website? The official website for AEterna Zentaris is http://www.aezsinc.com/. How can I contact AEterna Zentaris? AEterna Zentaris' mailing address is 315 Sigma Dr Ste 302D, SUMMERVILLE, SC 29486-7790, United States. The biopharmaceutical company can be reached via phone at +1-843-9003223. MarketBeat Community Rating for AEterna Zentaris (TSE AEZ)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 82 (Vote Outperform)Underperform Votes: 67 (Vote Underperform)Total Votes: 149MarketBeat's community ratings are surveys of what our community members think about AEterna Zentaris and other stocks. Vote "Outperform" if you believe AEZ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AEZ will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 4/22/2019 by MarketBeat.com StaffFeatured Article: How Does the Quiet Period Work?